↓ Skip to main content

Dove Medical Press

Prospective Application of Two New Pyridine-Based Zinc (II) Amide Carboxylate in Management of Alzheimer's Disease: Synthesis, Characterization, Computational and in vitro Approaches

Overview of attention for article published in Drug Design, Development and Therapy, June 2021
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Above-average Attention Score compared to outputs of the same age and source (56th percentile)

Mentioned by

twitter
2 X users

Citations

dimensions_citation
8 Dimensions

Readers on

mendeley
14 Mendeley
Title
Prospective Application of Two New Pyridine-Based Zinc (II) Amide Carboxylate in Management of Alzheimer's Disease: Synthesis, Characterization, Computational and in vitro Approaches
Published in
Drug Design, Development and Therapy, June 2021
DOI 10.2147/dddt.s311619
Pubmed ID
Authors

Rehman Zafar, Humaira Naureen, Muhammad Zubair, Khadija Shahid, Muhammad Saeed Jan, Samar Akhtar, Hammad Ahmad, Wajeeha Waseem, Ali Haider, Saqib Ali, Muhammad Tariq, Abdul Sadiq

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 14 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 14 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 2 14%
Researcher 2 14%
Student > Doctoral Student 1 7%
Unspecified 1 7%
Lecturer 1 7%
Other 1 7%
Unknown 6 43%
Readers by discipline Count As %
Chemistry 3 21%
Pharmacology, Toxicology and Pharmaceutical Science 1 7%
Unspecified 1 7%
Psychology 1 7%
Biochemistry, Genetics and Molecular Biology 1 7%
Other 0 0%
Unknown 7 50%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 05 July 2021.
All research outputs
#15,181,325
of 25,392,582 outputs
Outputs from Drug Design, Development and Therapy
#823
of 2,269 outputs
Outputs of similar age
#223,232
of 459,810 outputs
Outputs of similar age from Drug Design, Development and Therapy
#26
of 64 outputs
Altmetric has tracked 25,392,582 research outputs across all sources so far. This one is in the 38th percentile – i.e., 38% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,269 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.1. This one has gotten more attention than average, scoring higher than 62% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 459,810 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 49th percentile – i.e., 49% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 64 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 56% of its contemporaries.